147 related articles for article (PubMed ID: 36882122)
41. Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo.
Stein U; Walther W; Lemm M; Naundorf H; Fichtner I
Int J Cancer; 1997 Sep; 72(5):885-91. PubMed ID: 9311609
[TBL] [Abstract][Full Text] [Related]
42. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
43. A novel compound RY10-4 downregulates P-glycoprotein expression and reverses multidrug-resistant phenotype in human breast cancer MCF-7/ADR cells.
Xue P; Yang X; Liu Y; Xiong C; Ruan J
Biomed Pharmacother; 2014 Oct; 68(8):1049-56. PubMed ID: 25455158
[TBL] [Abstract][Full Text] [Related]
44. Elucidation of the sugar recognition ability of the lectin domain of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 by using unnatural glycopeptide substrates.
Yoshimura Y; Nudelman AS; Levery SB; Wandall HH; Bennett EP; Hindsgaul O; Clausen H; Nishimura S
Glycobiology; 2012 Mar; 22(3):429-38. PubMed ID: 22042768
[TBL] [Abstract][Full Text] [Related]
45. Expression of three UDP-N-acetyl-alpha-D-galactosamine:polypeptide GalNAc N-acetylgalactosaminyltransferases in adenocarcinoma cell lines.
Sutherlin ME; Nishimori I; Caffrey T; Bennett EP; Hassan H; Mandel U; Mack D; Iwamura T; Clausen H; Hollingsworth MA
Cancer Res; 1997 Nov; 57(21):4744-8. PubMed ID: 9354435
[TBL] [Abstract][Full Text] [Related]
46. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
[TBL] [Abstract][Full Text] [Related]
47. Polypeptide N-acetylgalactosaminyltransferase-6 expression independently predicts poor overall survival in patients with lung adenocarcinoma after curative resection.
Li Z; Yamada S; Wu Y; Wang KY; Liu YP; Uramoto H; Kohno K; Sasaguri Y
Oncotarget; 2016 Aug; 7(34):54463-54473. PubMed ID: 27276675
[TBL] [Abstract][Full Text] [Related]
48. Induction of multidrug resistance (MDR) by transfection of MCF-10A cell line with c-Ha-ras and c-erbB-2 oncogenes.
Sabbatini AR; Basolo F; Valentini P; Mattii L; Calvo S; Fiore L; Ciardiello F; Petrini M
Int J Cancer; 1994 Oct; 59(2):208-11. PubMed ID: 7927921
[TBL] [Abstract][Full Text] [Related]
49. Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins--towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation.
Daskalova SM; Radder JE; Cichacz ZA; Olsen SH; Tsaprailis G; Mason H; Lopez LC
BMC Biotechnol; 2010 Aug; 10():62. PubMed ID: 20735851
[TBL] [Abstract][Full Text] [Related]
50. Molecular basis for the presence of glycosylated onco-foetal fibronectin in oral carcinomas: the production of glycosylated onco-foetal fibronectin by carcinoma cells.
Wandall HH; Dabelsteen S; Sørensen JA; Krogdahl A; Mandel U; Dabelsteen E
Oral Oncol; 2007 Mar; 43(3):301-9. PubMed ID: 16857413
[TBL] [Abstract][Full Text] [Related]
51. Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds.
Kars MD; Iseri OD; Gündüz U; Ural AU; Arpaci F; Molnár J
Anticancer Res; 2006; 26(6B):4559-68. PubMed ID: 17201178
[TBL] [Abstract][Full Text] [Related]
52. A novel human UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates.
Bennett EP; Hassan H; Hollingsworth MA; Clausen H
FEBS Lett; 1999 Oct; 460(2):226-30. PubMed ID: 10544240
[TBL] [Abstract][Full Text] [Related]
53. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
[TBL] [Abstract][Full Text] [Related]
54. Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines.
Laurençot CM; Scheffer GL; Scheper RJ; Shoemaker RH
Int J Cancer; 1997 Sep; 72(6):1021-6. PubMed ID: 9378536
[TBL] [Abstract][Full Text] [Related]
55. Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3.
Wandall HH; Hassan H; Mirgorodskaya E; Kristensen AK; Roepstorff P; Bennett EP; Nielsen PA; Hollingsworth MA; Burchell J; Taylor-Papadimitriou J; Clausen H
J Biol Chem; 1997 Sep; 272(38):23503-14. PubMed ID: 9295285
[TBL] [Abstract][Full Text] [Related]
56. Histone deacetylase inhibitor reverses multidrug resistance by attenuating the nucleophosmin level through PI3K/Akt pathway in breast cancer.
Chen SY; Zheng XW; Cai JX; Zhang WP; You HS; Xing JF; Dong YL
Int J Oncol; 2016 Jul; 49(1):294-304. PubMed ID: 27211281
[TBL] [Abstract][Full Text] [Related]
57. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
[TBL] [Abstract][Full Text] [Related]
58. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells.
Brockhausen I; Yang JM; Burchell J; Whitehouse C; Taylor-Papadimitriou J
Eur J Biochem; 1995 Oct; 233(2):607-17. PubMed ID: 7588808
[TBL] [Abstract][Full Text] [Related]
59. Specific in vitro O-glycosylation of human granulocyte-macrophage colony-stimulating-factor-derived peptides by O-glycosyltransferases of yeast and rat liver cells.
Lorenz C; Strahl-Bolsinger S; Ernst JF
Eur J Biochem; 1992 May; 205(3):1163-7. PubMed ID: 1576999
[TBL] [Abstract][Full Text] [Related]
60. A functional polypeptide N-acetylgalactosaminyltransferase (PGANT) initiates O-glycosylation in cultured silkworm BmN4 cells.
Xu J; Morio A; Morokuma D; Nagata Y; Hino M; Masuda A; Li Z; Mon H; Kusakabe T; Lee JM
Appl Microbiol Biotechnol; 2018 Oct; 102(20):8783-8797. PubMed ID: 30136207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
